Using AI Created Digital Twins to Accelerate Clinical Trials
The Bio Report
00:00
Is There a Need for a Digital Twin in All Simers Disease?
Charles fisher, founder an co of unlearned ai. He says there is a real need for this type of synthetic control orm in rare diseases. Charles: We'ree preparing a sort of huge data dump of informationvalidation data about our approach in alseimers disease. If you want to drop us a lineor interested in sponsoring this potguess, send femal to danny at laben media group dot com.
Transcript
Play full episode
